/
/
पॉलीएनहाइड्राइड आईएल -1 नैनोपार्टिकल्स की विवो एंटीट्यूमर गतिविधि का मूल्यांकन
A subscription to JoVE is required to view this content. Sign in or start your free trial.
1Interdisciplinary Graduate Program in Human Toxicology,University of Iowa, 2Department of Pathology,University of Iowa, 3Department of Chemical and Biological Engineering, College of Engineering,Iowa State University, 4Nanovaccine Institute,Iowa State University, 5Division of Pharmaceutics and Translational Therapeutics, College of Pharmacy,University of Iowa, 6Holden Comprehensive Cancer Center,University of Iowa, 7Department of Oral Pathology, Radiology and Medicine, College of Dentistry,University of Iowa
Chapters
- 00:04Introduction
- 00:55Preparation and Maintenance of HNSCC Cell Line
- 02:38Tumor Implantation
- 03:14Blood Collection and Serum Separation
- 04:20Multiplexing of Collected Serum
- 04:51Collection of Tumor and Inguinal Lymph Node and Preparation of Single-Cell Suspension
- 05:58FACS Staining of Single-Cell Suspension
- 07:42Results: IL-1α Antitumor Activity in HNSCC Mouse Model
- 09:03Conclusion
